![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | C07D 401/14 | (2006.01) |
C07D 401/04 | (2006.01) | ||
C07D 231/20 | (2006.01) | ||
A61K 31/455 | (2006.01) | ||
A61P 11/00 | (2006.01) |
(11) | Patento numeris | 3551622 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17826629.2 |
Europos patento paraiškos padavimo data | 2017-12-08 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-10-16 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-07 |
(46) | Apibrėžties vertimo paskelbimo data | 2021-02-25 |
(86) | Numeris | PCT/US2017/065425 |
Data | 2017-12-08 |
(87) | Numeris | WO 2018/107100 |
Data | 2018-06-14 |
(30) | Numeris | Data | Šalis |
201662432537 P | 2016-12-09 | US |
(72) |
ABELA, Alexander, Russell, US
ALCACIO, Timothy, US
ANDERSON, Corey, US
ANGELL, Paul, Timothy, US
BAEK, Minson, US
CLEMENS, Jeremy, J., US
CLEVELAND, Thomas, US
FERRIS, Lori, Ann, US
GROOTENHUIS, Peter Diederik, Jan, US
GROSS, Raymond, Stanley, US
GULEVICH, Anton, US
HADIDA RUAH, Sara, Sabina, US
HSIA, Clara, Kuang-Ju, US
HUGHES, Robert, M., US
JOSHI, Pramod, Virupax, US
KANG, Ping, US
KESHAVARZ-SHOKRI, Ali, US
KHATUYA, Haripada, US
KRENITSKY, Paul, John, US
MCCARTNEY, Jason, US
MILLER, Mark, Thomas, US
PARASELLI, Prasuna, US
PIERRE, Fabrice Jean, Denis, US
SHI, Yi, US
SHRESTHA, Muna, US
SIESEL, David, Andrew, US
STAVROPOULOS, Kathy, US
TERMIN, Andreas, P., US
UY, Johnny, US
VAN GOOR, Fredrick, F., US
YOUNG, Tomothy, John, US
ZHOU, Jinglan, US
|
(73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
(74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Cistinės fibrozės transmembraninio laidumo reguliatoriaus moduliatorius, farmacinė kompozicija, gydymo būdai, ir moduliatoriaus gamybos būdas |
MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR |
Mokėjimo data | Galiojimo metai | Suma | |
2024-11-19 | 8 | 185.00 EUR |
2025-12-08 |